Proteus Digital Health IPO

Proteus Digital Health is a biotechnology company focused on creating a new category of pharmaceuticals: Digital Medicines, which include drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making, and data analytics to serve the needs of doctors and health systems.

Register for Details

For more details on financing and valuation for Proteus Digital Health, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Who are Proteus Digital Health's major investors?

Kaiser Permanente Ventures
Sailing Capital
Otsuka Pharmaceuticals
The Carlyle Group

Proteus Digital Health Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
4/15/2016 Series H $50MM raised $XXX.XX $XXX.XX
7/29/2014 Series G $172MM raised $XXX.XX $XXX.XX
5/2/2013 Series F $62.5MM raised $XXX.XX $XXX.XX
12/26/2009 Series E $35MM raised $XXX.XX $XXX.XX
10/15/2008 Series D $32.05MM raised $XXX.XX $XXX.XX
8/15/2008 Series C $34.02MM raised $XXX.XX $XXX.XX
6/23/2004 Series B $11.03MM raised $XXX.XX $XXX.XX
12/16/2003 Series A $750K raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Proteus Digital Health

Forge green plus iconForge green minus icon

What is Proteus Digital Health funding to date?

Proteus Digital Health has raised $397.36MM with the following series:
$750K raised for Series A,$11.03MM raised for Series B,$34.02MM raised for Series C,$32.05MM raised for Series D,$35MM raised for Series E,$62.5MM raised for Series F,$172MM raised for Series G,$50MM raised for Series H.
Forge green plus iconForge green minus icon

When was Proteus Digital Health founded?

Proteus Digital Health was founded in 2001.
Updated on: Jun 12, 2022